Skip to Content

CellaVision AB Bearer Shs CLVSF

Morningstar Rating
$24.21 +3.97 (19.61%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CLVSF is trading at a 314% premium.
Price
$24.12
Fair Value
$83.63
Uncertainty
Very High
1-Star Price
$42.33
5-Star Price
$87.96
Economic Moat
Zyxn
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CLVSF is a good fit for your portfolio.

Trading Information

Previous Close Price
$20.24
Day Range
$24.2124.21
52-Week Range
$16.7224.21
Bid/Ask
$0.00 / $24.74
Market Cap
$577.45 Mil
Volume/Avg
100 / 564

Key Statistics

Price/Earnings (Normalized)
43.37
Price/Sales
8.46
Dividend Yield (Trailing)
0.86%
Dividend Yield (Forward)
0.86%
Total Yield
0.86%

Company Profile

CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers/software.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
237

Comparables

Valuation

Metric
CLVSF
LINC
BICO
Price/Earnings (Normalized)
43.373.74
Price/Book Value
8.311.271.05
Price/Sales
8.461.46
Price/Cash Flow
29.71
Price/Earnings
CLVSF
LINC
BICO

Financial Strength

Metric
CLVSF
LINC
BICO
Quick Ratio
1.99167.521.74
Current Ratio
2.92167.522.52
Interest Coverage
71.15309.95−20.02
Quick Ratio
CLVSF
LINC
BICO

Profitability

Metric
CLVSF
LINC
BICO
Return on Assets (Normalized)
15.59%0.08%−4.62%
Return on Equity (Normalized)
20.42%0.08%−7.26%
Return on Invested Capital (Normalized)
17.90%−0.31%−6.72%
Return on Assets
CLVSF
LINC
BICO
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
KdxghsfgRtqhzq$177.5 Bil
Stryker Corp
SYK
BnvfdmlvwNlbw$129.9 Bil
Boston Scientific Corp
BSX
FgwthybyNfnckg$114.0 Bil
Medtronic PLC
MDT
KwjsrbqdkNptmw$101.9 Bil
Edwards Lifesciences Corp
EW
GncxsgplwgVymrwky$52.1 Bil
DexCom Inc
DXCM
DrxtltdcgfSmbh$44.2 Bil
Koninklijke Philips NV ADR
PHG
LcstppnwVxwzvgc$24.3 Bil
Zimmer Biomet Holdings Inc
ZBH
XsfzsrnqRgy$22.7 Bil
Steris PLC
STE
FfjkdfcpJqnkf$22.2 Bil
Align Technology Inc
ALGN
TvrmmdvwGjpbtr$18.9 Bil

Sponsor Center